Recent events
Recent events tied to this brand in public sources.
Back to profile64 entries · Page 3 of 4
2020
Bayer and Prospera partner on digital solutions for greenhouse growers
Bayer and Prospera Technologies entered into a strategic partnership to develop digital solutions for vegetable greenhouse growers. The initial rollout and in-field exploration were planned to begin in Mexico in July 2020.
2020
Bayer reaches Roundup settlement agreement
Bayer agreed to a roughly $10.5 billion deal to settle tens of thousands of lawsuits brought by U.S. plaintiffs alleging that its Roundup herbicide causes cancer. The reported agreement included about $9.5 billion for claims represented by lawyers for roughly 95,000 plaintiffs and about $1.1 billion for a panel to evaluate whether the product causes cancer.
2020
Bayer reaches settlements over Roundup, dicamba and PCB claims
Bayer reached settlements resolving claims involving Roundup, dicamba-related crop damage and PCB pollution. The Roundup settlement addresses claims alleging the weed killer caused cancer; the source says the agreement includes no admission of liability. Bayer will pay farmers $400 million for dicamba crop-damage claims and roughly $650 million to resolve PCB waterway-pollution cases, with a separate $170 million agreement concerning PCB claims by three government plaintiffs.
2020
Bayer announces settlements of Roundup, dicamba and PCB litigation
Bayer announced agreements to settle Roundup cancer litigation, dicamba drift litigation and some PCB water litigation exposure in the United States. The article reports the settlement amounts and notes that some agreements remain subject to court approval.
2020
Bayer and MassBio launch joint mentorship program
Bayer and MassBio announced the launch of the Bayer-MassCONNECT Asia joint mentorship program for early-stage life-sciences entrepreneurs and researchers, particularly in China and Asia. The program connects participants with experts and resources in Massachusetts.
2020
WaveForm Diabetes and Bayer enter commercial agreement for China glucose monitoring solutions
WaveForm Diabetes announced a commercial agreement with Bayer to provide continuous glucose monitoring solutions in China. WaveForm will develop a 15-day-wear CGM, while Bayer will handle commercialization, distribution, sales, and customer support in mainland China.
2020
D.C. sues Monsanto over PCB pollution allegations
The District of Columbia sued Monsanto and affiliated companies, alleging that they knowingly manufactured, promoted and sold toxic chemicals that polluted local waterways. Bayer, which acquired Monsanto, denied that Monsanto used or dumped PCBs into the District’s waterways and said it would respond to the complaint.
2020
Bayer partners with PHRI on COVID-19 clinical research
Bayer's Canadian arm teamed up with the Population Health Research Institute to launch a clinical research programme seeking potential COVID-19 treatments. The programme includes two studies evaluating combination therapies, including Bayer's chloroquine and interferon beta-1b.
2020
WuXi Biologics completed acquisition of Bayer manufacturing plant
WuXi Biologics announced that it completed the acquisition of a drug product manufacturing plant in Leverkusen, Germany, from Bayer. WuXi Biologics took over plant operations and purchased the plant equipment.
2020
Bayer launches Saudi recruitment campaign
Bayer launched the digitally led #MoveForwardwithBayer campaign in Saudi Arabia to recruit local talent. The company said it aims to recruit more than 140 additional team members by 2021.
2020
Bayer agrees to draft settlement terms in Roundup cases
A report said Bayer agreed to draft settlement terms with law firms representing tens of thousands of people alleging its Roundup weedkiller causes cancer. The source described the terms as a draft, not a completed settlement.
2020
Bayer partners with Agribazaar on farming projects in India
Bayer said it had partnered with agritech firm Agribazaar for its Better Life Farming projects in India. Agribazaar will provide smallholder farmers with marketplace linkages, while the companies will also work to improve access to crop advice and agricultural technologies.
2020
Bayer partners with XAG to offer agricultural drones
Bayer partnered with China's XAG to offer drones as solutions for crop cultivation; the article says Filipino farmers will have access to drones that map farms or collect crop-growth information remotely.
2020
Jury orders Bayer and BASF to pay damages over dicamba herbicide damage
A U.S. jury found Bayer and BASF liable in a farmer's case alleging that dicamba herbicide produced by the companies drifted onto and severely damaged his peach orchard, and awarded $15 million in actual damages and $250 million in punitive damages. Bayer said it would appeal.
2020
Bayer announces coronavirus-relief donations for China
Bayer announced donations of medicine and additional financial aid worth approximately €1.5 million to support people affected by the novel coronavirus outbreak in China. The donations were to be sent to the Chinese Red Cross.
2020
WuXi Biologics Germany agrees to acquire Bayer facility assets
WuXi Biologics Germany is to purchase the facility assets of Bayer's cGMP fill-and-finish biologics manufacturing plant in Leverkusen, Germany. The transaction consideration is to be paid in cash upon completion.
2020
Bayer announces collaboration with Exscientia
Bayer and Exscientia announced a collaboration involving Exscientia's AI-based drug discovery technology; the article describes work on cardiovascular and cancer diseases.
2020
Bayer bids a sharply reduced price for acarbose
In the second round of China’s centralized drug procurement, Bayer bid 5.42 yuan per box for acarbose, less than one-tenth of its previous price.
2019
Bayer appeals Roundup cancer verdict
Bayer said it had asked a US federal appeals court to reverse the $25 million judgment in Edwin Hardeman's case, which concerned his claim that Roundup caused his cancer.
2019
Bayer fined over Supradyn Kids advertising
Hungary's acting Competition Council fined Bayer €20,000 and ordered it to terminate communications for Supradyn Kids supplement products. The Council found that a television ad promoting Supradyn Kids multivitamins involved unfair commercial practices against consumers.